Most people on GLP-1 drugs can safely fast for Yom Kippur or other religious observances, but they may need to plan ahead, ...
Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. (“Beta Bionics” ...
First-of-its-kind study finds more than 70% of participants completed a 25-hour fast without significant complications, with ...
In 2024, continuous glucose monitoring devices hit the shelves for over-the-counter consumer use. Historically, these devices ...
China: A 40-week Phase 3b trial published in The Lancet Diabetes & Endocrinology has revealed that once-weekly semaglutide combined with basal insulin icodec achieved greater reductions in HbA1c and ...
Under the agreement, Elvinix gains an exclusive license to the GLP-1/gastrin dual-agonist patent families and an extensive ...
Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: BBNX) on behalf of investors that purchased or ...
A new Israeli study suggests that some adolescents and young adults with Type 1 diabetes may be able to go without food and drink for about 25 hours using automated insulin-delivery technology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results